Products Evaluation History
Since 1987, Texcell has acquired widely acknowledged expertise with the following products:
- plasma-derived products,
- monoclonal antibodies,
- recombinant proteins,
- animal-derived products (extracted from tissues or organs),
- vaccines,
- viral gene therapy vectors,
- cell therapy products,
- bone tissue,
- collagen,
- grafts,
- medical devices.
